Barbara R Schock

Suggest Changes
Learn More
We compared immune restoration in patients who suppressed human immunodeficiency virus type 1 replication after treatment with a protease inhibitor (PI) plus nevirapine or with 3 nucleoside(More)
BACKGROUND Human immunodeficiency virus type 1 (HIV-1)-specific cellular immunity contributes to the control of HIV-1 replication. HIV-1-infected volunteers who were receiving antiretroviral therapy(More)
CONTEXT Approaches to preserve or enhance immune function in HIV-1 infection are needed. OBJECTIVES To examine the ability of daily low-dose interleukin-2 (IL-2) in combination with antiretroviral(More)